March 10, 2025
Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer
Tethis S.p.A. collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer…
January 14, 2025
Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy
Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods…
September 3, 2024
Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer
Tethis S.p.A. collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage…
July 19, 2021
Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board of Directors
Bastiaan van der Baan and Miro Venturi join Tethis as Independent Members of the Board…
March 24, 2021
Study published in BJC shows strong performance of Tethis’ liquid biopsy test in early stage breast cancer
Tethis S.p.A announced the publication of a pilot study in early breast cancer showing the…
December 17, 2020
Tethis’ SAB appoints Prof. Aceto, Ph.D, as Chairman
Tethis S.p.A announced today that in the first meeting of the reconfirmed Scientific Advisory Board…
Recent Comments